Personalis ROA 2018-2024 | PSNL

Current and historical return on assets (ROA) values for Personalis (PSNL) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Personalis ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2024-06-30 $-0.08B $0.19B -39.38%
2024-03-31 $-0.09B $0.20B -41.52%
2023-12-31 $-0.11B $0.23B -44.81%
2023-09-30 $-0.11B $0.23B -43.42%
2023-06-30 $-0.11B $0.25B -38.87%
2023-03-31 $-0.11B $0.27B -36.74%
2022-12-31 $-0.11B $0.29B -33.48%
2022-09-30 $-0.10B $0.32B -28.06%
2022-06-30 $-0.09B $0.36B -24.37%
2022-03-31 $-0.08B $0.38B -20.66%
2021-12-31 $-0.07B $0.40B -16.42%
2021-09-30 $-0.06B $0.41B -16.21%
2021-06-30 $-0.05B $0.38B -15.71%
2021-03-31 $-0.04B $0.40B -16.99%
2020-12-31 $-0.04B $0.25B -20.71%
2020-09-30 $-0.04B $0.25B -19.89%
2020-06-30 $-0.03B $0.15B -20.81%
2020-03-31 $-0.03B $0.15B -17.55%
2019-12-31 $-0.03B $0.16B -20.43%
2019-06-30 $-0.02B $0.19B -33.33%
2019-03-31 $-0.02B $0.00B inf%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.270B $0.073B
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Bausch Health Cos (BHC) Canada $3.597B 2.61
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00